EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Dual inhibition of FACT and RRM2 suppresses the progression of pancreatic ductal adenocarcinoma driven by the oncohistone H2BG53D

Tiantian Qin, Yi Ching Esther Wan, Shiman Hu, Jiaohua Chen, Xiaoxuan Zhu, Jiaqi Zhou, Yabin Chen, Xin Wang, Zongli Zheng, Landon Long Chan, Hoi Leong Xavier Wong, Haojie Jin und 4 weitere

Cell Reports · 2025

DOI: 10.1016/j.celrep.2025.116596 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Tiantian Qin und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, College of Biomedicine, City University of Hong Kong, Hong Kong SAR 999077, China; Key Laboratory of Biochip Techn…. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Ribonucleoside Diphosphate Reductase, Histones, Pancreatic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Government of the Hong Kong Special Administrative Region of the People, Research Grants Council, University Grants Committee, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalRibonucleoside Diphosphate ReductaseHistonesPancreatic NeoplasmsDNA-Binding ProteinsAnimalsHumansMiceDisease ProgressionCell Line, TumorNucleosomesMutation

Stichwörter der Autor:innen

CP: cancerCP: molecular biologyCRISPR-Cas9 screenFACTH2BG53DKPC modelPDACPDAC metastasisPDAC progressionRRM2oncohistonetherapeutic strategy

Substanzen

Ribonucleoside Diphosphate Reductaseribonucleotide reductase M2HistonesDNA-Binding ProteinsNucleosomes

Autor:innen und Institutionen

  • Department of Biomedical Sciences, College of Biomedicine, City University of Hong Kong, Hong Kong SAR 999077, China; Key Laboratory of Biochip Technology, Biotech and Health Centre, Shenzhen Research Institute of City…
  • Shenzhen Key Laboratory of Synthetic Genomics, Guangdong Provincial Key Laboratory of Synthetic Genomics, Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of…
  • Department of Surgery, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong SAR 999077, China.
  • Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR 999…
  • School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR, China.
  • State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200000, China.

Förderung

  • Government of the Hong Kong Special Administrative Region of the People
  • Research Grants Council, University Grants Committee
  • National Natural Science Foundation of China

Zitieren

APA

Qin, T., Wan, Y. C. E., Hu, S., Chen, J., Zhu, X., Zhou, J., Chen, Y., Wang, X., Zheng, Z., Chan, L. L., Wong, H. L. X., Jin, H., Han, J., Li, Q., Gan, H., & Chan, K. M. (2025). Dual inhibition of FACT and RRM2 suppresses the progression of pancreatic ductal adenocarcinoma driven by the oncohistone H2BG53D. Cell Reports. https://doi.org/10.1016/j.celrep.2025.116596

Vancouver

Qin T, Wan YCE, Hu S, Chen J, Zhu X, Zhou J, et al. Dual inhibition of FACT and RRM2 suppresses the progression of pancreatic ductal adenocarcinoma driven by the oncohistone H2BG53D. Cell Reports. 2025. doi:10.1016/j.celrep.2025.116596

BibTeX
@article{Qin2025,
  author = {Qin, Tiantian and Wan, Yi Ching Esther and Hu, Shiman and Chen, Jiaohua and Zhu, Xiaoxuan and Zhou, Jiaqi and Chen, Yabin and Wang, Xin and Zheng, Zongli and Chan, Landon Long and Wong, Hoi Leong Xavier and Jin, Haojie and Han, Junhong and Li, Qing and Gan, Haiyun and Chan, Kui Ming},
  title = {Dual inhibition of FACT and RRM2 suppresses the progression of pancreatic ductal adenocarcinoma driven by the oncohistone H2BG53D},
  journal = {Cell Reports},
  year = {2025},
  doi = {10.1016/j.celrep.2025.116596}
}
Kostenlos starten →